Paper630809
A radioimmunoassay for 1,25-dihydroxycholecalciferol.
Clemens TL and 5 others. Clin Sci Mol Med, 1978. Cited by 54 papers, by iCite.
Cite this record
ConductScience Library. A radioimmunoassay for 1,25-dihydroxycholecalciferol. Papers, record 630809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/630809
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dihydroxycholecalciferols | Major topic |
| Hydroxycholecalciferols | Major topic |
| Radioimmunoassay | Major topic |
| Animals | |
| Antibody Formation | |
| Cross Reactions | |
| Rabbits | |
| Serum Albumin, Bovine |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40980785 | 1,25-Dihydroxyvitamin D Testing in Clinical Practice: A Literature Review on Diagnostic Challenges Arising From Analytical Variability. | Cureus | 2025 | https://conductscience.org/library/papers/40980785 | PubMed |
| 35475448 | There is more to life than serum vitamin D: a lesson from the past. | Clin Sci (Lond) | 2022 | https://conductscience.org/library/papers/35475448 | PubMed |
| 25931412 | The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF). | Endocrine | 2015 | https://conductscience.org/library/papers/25931412 | PubMed |
| 25110467 | Vitamin D Deficiency and Its Health Consequences in Africa. | Clin Rev Bone Miner Metab | 2009 | https://conductscience.org/library/papers/25110467 | PubMed |
| 20511051 | Assessment and interpretation of circulating 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in the clinical environment. | Endocrinol Metab Clin North Am | 2010 | https://conductscience.org/library/papers/20511051 | PubMed |
| 17197173 | The assessment of circulating 25(OH)D and 1,25(OH)2D: where we are and where we are going. | J Steroid Biochem Mol Biol | 2007 | https://conductscience.org/library/papers/17197173 | PubMed |
| 7429331 | Treatment of bone disease after jejunoileal bypass for obesity with oral 1 alpha-hydroxyvitamin D3. | Gut | 1980 | https://conductscience.org/library/papers/7429331 | PubMed |
| 6688814 | Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6688814 | PubMed |
| 3872485 | Serum concentrations of vitamin D metabolites in untreated tuberculosis. | Thorax | 1985 | https://conductscience.org/library/papers/3872485 | PubMed |
| 3026959 | Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3. | Immunology | 1986 | https://conductscience.org/library/papers/3026959 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/630809
GET https://conductscience.org/api/papers/v1/630809/authors